Post-Traumatic Stress Disorder (PTSD) Therapeutics Market 2020-2024- Featuring AstraZeneca Plc, Bionomics Ltd., Among Others to Contribute to the Market Growth
The post-traumatic stress disorder (PTSD) therapeutics market is poised to grow by USD 909.86 mn during 2020-2024, progressing at a CAGR of over 9% during the forecast period.
Worried about the impact of COVID-19 on your Business? Here is an Exclusive report talking about Market scenarios, Estimates, the impact of lockdown, and Customer Behaviour.
The report on the post-traumatic stress disorder (PTSD) therapeutics market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.
The report offers an up-to-date analysis regarding the current global market scenario and the overall market environment. The market is driven by the rising prevalence of PTSD.
The post-traumatic stress disorder (PTSD) therapeutics market analysis includes product segment and geography landscape. This study identifies the emerging therapies for PTSD treatment as one of the prime reasons driving the post-traumatic stress disorder (PTSD) therapeutics market growth during the next few years.
This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.
The post-traumatic stress disorder (PTSD) therapeutics market covers the following areas:
Medium Chain Triglycerides (MCT) Market by Distribution Channel and Geography - Forecast and Analysis 2020-2024- The medium chain triglycerides (MCT) market size has the potential to grow by USD 481.40 million during 2020-2024, and the market's growth momentum will accelerate during the forecast period. To get extensive research insights: Click and get FREE sample report in minutes
Self-Monitoring Blood Glucose Strips Market by End-user and Geography - Forecast and Analysis 2020-2024-The self-monitoring blood glucose strips market size has the potential to grow by USD 10.96 billion during 2020-2024, and the market's growth momentum will accelerate during the forecast period. To get extensive research insights: Click and get FREE sample report in minutes
Key Topics Covered:
Executive Summary
Market Overview
Market Landscape
Market ecosystem
Value chain analysis
Market Sizing
Market definition
Market segment analysis
Market size 2019
Market outlook: Forecast for 2019 - 2024
Five Forces Analysis
Five Forces Summary
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition
Market Segmentation by Product
Market segments
Comparison by Product placement
Antidepressants - Market size and forecast 2019-2024
Anxiolytics - Market size and forecast 2019-2024
Other PTSD therapeutics - Market size and forecast 2019-2024
Market opportunity by Product
Customer landscape
Overview
Geographic Landscape
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2019-2024
APAC - Market size and forecast 2019-2024
Europe - Market size and forecast 2019-2024
South America - Market size and forecast 2019-2024
MEA - Market size and forecast 2019-2024
Key leading countries
Market opportunity by geography
Drivers, Challenges, and Trends
Market drivers
Volume driver - Demand led growth
Volume driver - Supply led growth
Volume driver - External factors
Volume driver - Demand shift in adjacent markets
Price driver - Inflation
Price driver - Shift from lower to higher priced units
Market challenges
Market trends
Vendor Landscape
Overview
Vendor landscape
Landscape disruption
Vendor Analysis
Vendors covered
Market positioning of vendors
AstraZeneca Plc
Azevan Pharmaceuticals Inc.
Bionomics Ltd.
Eli Lilly and Co.
GlaxoSmithKline Plc
H. Lundbeck AS
Mylan NV
Neurocrine Biosciences Inc.
Novartis International AG
Pfizer Inc.
Appendix
Scope of the report
Currency conversion rates for US$
Research methodology
List of abbreviations
Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio's in-depth research has direct and indirect COVID-19 impacted market research reports.
Register for a free trial today and gain instant access to 17,000+ market research reports.
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Guanajuato Silver Company Ltd. (the "Company" or "GSilver") announces a brokered, best-efforts Listed Issuer Financing Exemption private placement (the "Offering") consisting of units of the Company (the "Units") at a price of C$0.20 per Unit (the...
Customers Bancorp, Inc. :
First Quarter 2024 Highlights
Q1 2024 net income available to common shareholders was $45.9 million, or $1.40 per diluted share; ROAA was 0.94% and ROCE was 12.08%.
Q1 2024 core earnings* were $46.5 million, or $1.42...
Petrolympic Ltd. (the "Company", TSXV: PCQ) wishes to announce it has completed a non-brokered private placement (the "Offering") of 5,000,000 common shares of the Company on a flow-through basis ("FT Shares") at a price of $0.08 per FT Share, for...
Agnico Eagle Mines Limited ("Agnico Eagle" or the "Company") today reported financial and operating results for the first quarter of 2024.
"Building on a very strong close to 2023, we are reporting our second consecutive quarter of record...
OP Bancorp (the "Company") , the holding company of Open Bank (the "Bank"), today reported its financial results for the first quarter of 2024. Net income for the first quarter of 2024 was $5.23 million, or $0.34 per diluted common share, compared...
Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against QuidelOrtho Corporation ("QuidelOrtho" or the "Company") .
Class Period: February 18, 2022 ?...